Contrast-enhanced breast MRI for cancer detection using a commercially available system - A perspective

Clinical Imaging

Volumn 22, Issue 3, 1998, Pages 162-179

  Safir, Julian ^a   Zito, Joseph L ^a   Gershwind, Mark E ^a   Faegenburg, David ^a   Tobin, Corinne E ^a   Cayea, Paul D ^a   Wortman, William J ^a   Sclafani, Lisa M ^b   Maurer, Virginia E ^c  

^a Nassau Radiologic Group   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast neoplasms, diagnosis; Breast neoplasms, MR; Breast neoplasms, postoperative; Breast neoplasms, staging; Magnetic resonance, MR contrast enhancement

Indexed keywords

GADODIAMIDE;

BREAST TUMOR; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DEVICE; FEMALE; GUIDE WIRE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRACTICE GUIDELINE; REVIEW;

ADULT; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY;

EID: 0031954999     PISSN: 08997071     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-7071(97)00121-6     Document Type: Review

References (56)

1. Wingo PA, Tong T, Bolden S Cancer statistics, 1995. CA. 45:1995;8-30.
2. Ries LAG, Miller BA, Hankley BF, et al. Cancer Statistics Review 1973-1991: Tables and Graphs. National Institute of Health Publication No. 94-2789. Bethesda, MD: National Cancer Institute, 1994.
3. Heywang-Kobrunner SH Introduction. Heywang-Kobrunner SH, Beck R Contrast-Enhanced MRI of the Breast. 2:1996;1-6 Springer-Verlag, Berlin.
4. Wagner SK Breast MRI. limited specificity and high cost hamper acceptance Diagn Imaging. 18:1996;40-46.
5. Heywang-Kobrunner SH Contrast-enhanced magnetic resonance imaging of the breasts. Invest Radiol. 29:1994;94-104.
6. Harms SE, Flanig DP, Hesley KLet al. MR imaging of the breast rotating delivery of excitation off resonance. clinical experience with pathologic correlation Radiology. 187:1993;493-501.
7. Heywang-Kobrunner SH Technique. Heywang-Kobrunner SH, Beck R Contrast-Enhanced MRI of the Breast. 2:1996;7-56 Springer-Verlag, Berlin.
8. Martin B, EI Yousef SJ Transverse relaxation time values in MR imaging of normal breast during menstrual cycle. J Comput Assist Tomogr. 10:1986;924-927.
9. Weinreb JC, Newstead G MR imaging of the breast. Radiology. 196:1995;593-610.
10. Heywang-Kobrunner SH, Huynh AT, Viehweg P, Harke W, Requandt H, Paprosch I Prototype breast coil for MR-guided needle localization. J Comput Assist Tomogr. 18:1994;876-881.
11. Orel SG, Schnall MG, Newman RW, Powell CM, Torosian MH, Rosato EF MR imaging-guided localization and biopsy of breast lesions. initial experience Radiology. 193:1994;97-102.
12. Fischer U, Vosshenrich R, Doler W, Hamadeh A, Oestmann JW, Grabbe E MR imaging-guided biopsy breast intervention. experience with two systems Radiology. 195:1995;533-538.
13. Obdeijn IMA, Kuijpers TJA, van Dijk P, Wiggers T, Oudkerk M MR lesion detection in a breast cancer population. J Magn Reson Imaging. 6:1996;849-854.
14. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W MR imaging of the breast with Gd-DTPA. use and limitations Radiology. 171:1989;95-103.
15. Revel D, Brasch RC, Paajanen Het al. Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology. 158:1986;319-323.
16. Van Dijke CF, Brasch RC, Roberts TPet al. Mammary carcinoma model. correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density Radiology. 198:1996;813-818.
17. Brasch RC, Weinmann HJ, Wesbey GE Contrast-enhanced NMR imaging. animal studies using gadolinium-DTPA complex AJR. 142:1984;625-630.
18. Piccoli CW, Greer JG, Mitchell DG Breast MR imaging for cancer detection and implant evaluation. potential pitfalls Radiographics. 16:1996;63-75.
19. Heywang-Kobrunner SH Appearance of various tissue and lesions. Heywang-Kobrunner SH, Beck R Contrast-Enhanced MRI of the Breast. 2:1996;57-156 Springer-Verlag, Berlin.
20. Gilles R, Guinebretiere JM, Lucidarme Oet al. Nonpalpable breast tumors. diagnosis with contrast-enhanced subtraction dynamic MR imaging Radiology. 191:1994;625-631.
21. Orel SB, Schnall MD, LiVolsi VA, Troupin RH Suspicious breast lesions. MR imaging with radiologic-pathologic correlation Radiology. 190:1994;485-493.
22. Harms SE, Flamig DP, Hesley KL, Evans WP Magnetic resonance imaging of the breast. Magnet Reson Q. 8:1992;139-155.
23. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ Breast MR imaging with commercially available techniques. radiologic-pathologic correlation Radiology. 196:1995;143-152.
24. Stomper PC, Herman S, Klippenstein DLet al. Suspect breast lesions. findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features Radiology. 197:1995;387-395.
25. Heywang-Kobrunner SH Clinical application of contrast-enhanced MRI. Heywang-Kobrunner SH, Beck R Contrast-Enhanced MRI of the Breast. 2:1996;157-204 Springer-Verlag, Berlin.
26. Heywan-Kobrunner SH, Haustein J, Pohl Cet al. Contrast-enhanced MR imaging of the breast. comparison of two different doses of gadopentate dimeglumine Radiology. 191:1994;639-646.
27. Nunes LW, Orel SG, Schnall MD Diagnostic accuracy and lesion characteristic predictive values in the MR imaging evaluation of breast masses. Radiology. 193:1994;267.
28. Boetes C, Barentz JO, Mus RD MR characterization of breast lesions with a gadolinium-enhanced Turbo-FLASH subtraction technique. Radiology. 193:1994;777-781.
29. Carter CL, Allen C, Henson DE Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 63:1989;181-187.
30. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V Effect of age, breast density and family history on the sensitivity of first screening mammography. JAMA. 276:1996;33-38.
31. Bird R, Wallace T, Yankasas B Analysis of cancers missed at screening mammography. Radiology. 184:1992;613-617.
32. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V Likelihood ratios for modern screening mammography. risk ratios of breast cancer based on age and mammographic interpretation JAMA. 276:1996;39-43.
33. Lerman C, Narod S, Schulman Ket al. BRCA1 testing in families with hereditary breast-ovarian cancer. a prospective study of patient decision making and outcomes JAMA. 275:1996;1885-1892.
34. Vernesi U, Sacozzi R, Vecchi Met al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 305:1981;6-11.
35. Fischer B, Redmond C, Poisson Ret al. Eight-year results of a randomized trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 320:1989;822-828.
36. Kurtz JM, Jacquemier J, Amalric Ret al. Breast-conserving therapy for macroscopically multiple cancers. Ann Surg. 212:1990;38-44.
37. Dutt PL, Page DL Multicentricity of in situ and invasive carcinoma. Coeland EM Epidemiology and natural history of breast cancer. 1991;299-308 WB Saunders, Philadelphia.
38. Singletary SE, McNeese M Segmental mastectomy and irradiation in the treatment of breast cancer. Am J Clin Oncol. 11:1988;679-683.
39. Orel SG, Schnall MD, Powell CMet al. Staging of suspected breast cancer. effect of MR imaging and MR-guided biopsy Radiology. 196:1995;115-122.
40. Harms SE, Flamig DP, Hesley KLet al. Fat suppressed three-dimensional MR imaging of the breast. Radiographics. 13:1993;247-267.
41. Boetes C, Mus RD, Holland Ret al. Breast tumors. comparative accuracy of MR imaging relative to mammography and US for demonstrating extent Radiology. 197:1995;743-747.
42. Stelling CB Breast cancer staging with contrast material-enhanced MR imaging. should it change patient treatment? Radiology. 196:1995;16-18.
43. Stomper PC, VanVoorhis BJ, Ravnikar VA, Meyer JE Mammographic changes associated with postmenopausal replacement therapy. a longitudinal study Radiology. 174:1990;487-490.
44. Krecke KN, Gisould JJ Invasive lobular carcinoma of the breast. mammographic findings and extent of disease at diagnosis in 184 patients AJR. 161:1993;957-960.
45. Rodenko GN, Harms SE, Pruneda JM, Farell RS, Evans WP, Copit DS, Krakos PA, Flamig DP MR imaging in the management before surgery of lobular carcinoma of the breast. correlation with pathology AJR. 167:1996;1415-1419.
46. Baron PL, Moore MP, Kinne DWet al. Occult breast cancer presenting with axillary metastases. updated management R Arch Surg. 125:1990;210-215.
47. Dao TH, Rahmouni A, Campana F, Laurent M, Asselian B, Fourquet A Tumor recurrence versus fibrosis in the irradiated breast. differentiation with dynamic gadolinium-enhanced MR imaging Radiology. 187:1993;751-755.
48. Heywang-Kobrunner SH, Schlegel A, Beck Ret al. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assit Tomogr. 17:1993;891-900.
49. Fajardo LL, Harvey J, Mc Aleese KA, Roberts CC, Granstrom P Breast cancer diagnosis in women with subglandular silicone gel-filled augmentation implants. Radiology. 194:1995;859-862.
50. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 275:1996;913-918.
51. Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC MR imaging of ductal carcinoma in situ. Radiology. 202:1997;413-420.
52. Gilles R, Meunier M, Lucidarme O, Zafrani B, Guinebretiere JM, Tardivon AA, Le Gal M, Vanel D, Neuenschwander S, Arrigada R Clustered breast microcalcifications. evaluation with dynamic contrast-enhanced subtraction MRI J Comput Assist Tomogr. 20:1996;9-14.
53. Sickles EA, Parker SH Appropriate role of core breast biopsy in management of probably benign lesions. Radiology. 188:1993;313-314.
54. Turkat TJ, Klein BD, Polan RL, Richman RH Dynamic MR mammography for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging. 4:1994;563-568.
55. Elvecrog EL, Lechner MC, Nelson MT Nonpalpable breast lesions. correlation of stereotaxic large-core needle biopsy and surgical biopsy results Radiology. 188:1993;453-455.
56. Azavedo E, Auer G, Svane G Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet. 1:1989;1033-1036.